Top

Published in:

01-01-2010 | Commentary

Leptin therapy in lipodystrophy

Authors: D. B. Savage, S. O’Rahilly

Published in: Diabetologia | Issue 1/2010

Excerpt

Although much maligned, fat is an essential organ with important mechanical and metabolic roles. Like many good things in life, too much (obesity) or too little of it (lipodystrophy) is unhealthy, whereas maintaining some reserve capacity (leanness) to buffer and accommodate modern eating habits is ideal. So why do we need some fat? …

Frayn KN (2002) Adipose tissue as a buffer for daily lipid flux. Diabetologia 45:1201–1210CrossRefPubMed

Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355CrossRefPubMed

Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867CrossRefPubMed

Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507–520CrossRefPubMed

Garg A (2000) Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 85:1776–1782CrossRefPubMed

Gavrilova O, Marcus-Samuels B, Graham D et al (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271–278CrossRefPubMed

Rodeheffer MS, Birsoy K, Friedman JM (2008) Identification of white adipocyte progenitor cells in vivo. Cell 135:240–249CrossRefPubMed

Pelleymounter MA, Cullen MJ, Baker MB et al (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540–543CrossRefPubMed

Farooqi IS, Jebb SA, Langmack G et al (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879–884CrossRefPubMed

10.

Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL (1999) Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401:73–76CrossRefPubMed

11.

Oral EA, Simha V, Ruiz E et al (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570–578CrossRefPubMed

12.

Park JY, Javor ED, Cochran EK, DePaoli AM, Gorden P (2007) Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy. Metabolism 56:508–516CrossRefPubMed

13.

Mulligan K, Khatami H, Schwarz JM et al (2009) The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J Clin Endocrinol Metab 94:1137–1144CrossRefPubMed

14.

Chong AY, Lupsa BC, Cochran EK, Gorden P (2010) Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia. doi:10.1007/s00125-009-1502-9

15.

Javor ED, Moran SA, Young JR et al (2004) Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. J Clin Endocrinol Metab 89:3199–3207CrossRefPubMed

16.

Farooqi IS, Matarese G, Lord GM et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093–1103PubMed

17.

Prieur X, Tung YC, Griffin JL, Farooqi IS, O’Rahilly S, Coll AP (2008) Leptin regulates peripheral lipid metabolism primarily through central effects on food intake. Endocrinology 149:5432–5439CrossRefPubMed

18.

Leinninger GM, Jo YH, Leshan RL et al (2009) Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab 10:89–98CrossRefPubMed

19.

Petersen KF, Oral EA, Dufour S et al (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345–1350PubMed

20.

Robbins DC, Danforth E Jr, Horton ES, Burse RL, Goldman RF, Sims EA (1979) The effect of diet on thermogenesis in acquired lipodystrophy. Metabolism 28:908–916CrossRefPubMed

21.

Utzschneider KM, Trence DL (2006) Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy. Diabetes Care 29:1380–1382CrossRefPubMed

Title: Leptin therapy in lipodystrophy
Authors: D. B. Savage
S. O’Rahilly
Publication date: 01-01-2010
Publisher: Springer-Verlag
Published in: Diabetologia / Issue 1/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-009-1545-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2010

Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients

Erratum to: Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro

Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys

Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]

Effects of exenatide on circulating glucose, insulin, glucagon, cortisol and catecholamines in healthy volunteers during exercise

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials